Simple jQuery Dropdowns

Browsing by Author Vichien Srimuninnimit

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)
1-Mar-2002Association between estrogen receptor concentration in breast cancer tissue and bone mineral densitySutin Sriussadaporn; Sirirat Ploybutr; Supornpim Chearskul; Wannee Nitiyanant; Pairoj Sinlarat; Vichien Srimuninnimit; Monchaya Tanlakit; Surachat Chakrapee-Sirisuk; Sathit Vannasaeng; Apichati Vichayanrat; Mahidol University
16-Oct-2013Benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patientsSagita Dewi; Stig Larsen; Vichien Srimuninnimit; Yen Shen Lu; Tjakra Manuaba; Steen Lindkær-Jensen; Norges veterinaerhogskole; Mahidol University; National Taiwan University Hospital; Universitas Udayana; Imperial College London
27-Nov-2014BP-C1 in the treatment of patients with stage IV breast cancer: A randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phaseStig Larsen; Kritiya Butthongkomvong; Alexey Manikhas; Ekaterina Trishkina; Elena Poddubuskaya; Marina Matrosova; Vichien Srimuninnimit; Steen Lindkær-Jensen; Norwegian University of Life Science; Udonthani Cancer Hospital; Dispensary; Leningrad Regional Oncological Hospital; Russian Academy of Medical Sciences; Mahidol University; Hammersmith Hospital
1-Jan-2013Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito; Osaka University; Osaka National Hospital; Aichi Cancer Center Hospital and Research Institute; National Cancer Center Hospital East; Gunma University Hospital; Prince of Songkla University; Mahidol University; Tokai University; Tokyo Metropolitan Komagome Hospital; Kumamoto University; Osaka Medical Center for Cancer and Cardiovascular Diseases; National Shikoku Cancer Center Hospital; Korea Cancer Center Hospital; National Kyushu Cancer Center; Sagara Hospital; Yonsei University College of Medicine; Novartis Pharmaceuticals Corporation; Cancer Institute Hospital of Japan Foundation for Cancer Research
1-Jan-2015Epidermal growth factor receptor mutation status in the treatment of non-small cell lung cancer: Lessons learnedDae Ho Lee; Vichien Srimuninnimit; Rebecca Cheng; Xin Wang; Mauro Orlando; Asan Medical Center; Mahidol University; Eli Lilly and Company; Eli Lilly Interamerica Inc.
1-Jul-2018Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A clinical trialMelanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Özgüroglu; Sergio J. Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J. Gradishar; Christina Arce; Antonia Ridolfi; Chinjune Lin; Fatima Cardoso; Champalimaud Foundation; Yonsei University Health System; University of New Mexico; Istanbul Üniversitesi; Centre Hospitalier Universitaire de Besancon; The University of Alabama at Birmingham; Le Centre Régional de Lutte Contre le Cancer Léon Bérard; Hospital de Clinicas de Porto Alegre; Novartis Pharma S.A.S.; Northwestern University Feinberg School of Medicine; Faculty of Medicine, Siriraj Hospital, Mahidol University; Universidade de Sao Paulo - USP; Institut Bergonie; Nagoya University; Novartis Pharmaceuticals Corporation; Instituto Brasileiro de Controle do Câncer
1-Jul-2012Ewing's sarcoma and primitive neuroectodermal tumour (ES/PNET) presenting as a breast massSuebwong Chuthapisith; Wilairat Prasert; Malee Warnnissorn; Kanapon Pradniwat; Vichien Srimuninnimit; Tamnit Angsusinha; Mahidol University
1-Mar-2016First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results from a Randomized Phase III TrialMark Boye; Xin Wang; Vichien Srimuninnimit; Jin Hyoung Kang; Chun Ming Tsai; Mauro Orlando; Tarun Puri; Jong Seok Kim; Narayan Rajan; James Chih Hsin Yang; Eli Lilly and Company; Mahidol University; The Catholic University of Korea; National Yang-Ming University Taiwan; Eli Lilly Interamerica Inc.; Eli Lilly Australia Pty Ltd.; National Taiwan University Hospital
1-Jan-2014First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trialJames Chih Hsin Yang; Jin Hyoung Kang; Tony Mok; Myung Ju Ahn; Vichien Srimuninnimit; Chia Chi Lin; Dong Wan Kim; Chun Ming Tsai; Helen Barraclough; Sedat Altug; Mauro Orlando; Keunchil Park; National Taiwan University Hospital; The Catholic University of Korea; Chinese University of Hong Kong; SungKyunKwan University, School of Medicine; Mahidol University; Seoul National University Hospital; Veterans General Hospital-Taipei; Eli Lilly and Company
1-Aug-2006Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II studyKei Siong Khoo; Syed Hasan Manzoor Zaidi; Vichien Srimuninnimit; Santai Song; Reena Nair; Corazon A. Ngelangel; Anita Bustam; William H.H. Reece; Manfred Lehnert; National Cancer Centre, Singapore; Baquai Institute of Oncology; Mahidol University; 307 Hospital of PLA; Tata Memorial Hospital; Philippine General Hospital; University of Malaya Medical Centre; Clinical Outcomes and Research Institute; Eli Lilly Asian Operations
1-Dec-2001Ketoconazole and flutamide in the treatment of disseminated Intravascular clotting from prostate cancer: A case report and reviewSurachat Chakrapee-Sirisuk; Kanchana Amornpichetkul; Sukon Visudhiphan; Tumtip Sangruchi; Vichien Srimuninnimit; Pairoj Sinlarat; Mahidol University
1-Jan-2000Phase II study of concurrent chemoradiotherapy for inoperable (Bulky) stage III (A/B) Non-Small Cell Lung Cancer (NSCLC) : A preliminary reportVorachai Ratanatharathorn; Puangthong Kraipiboon; Savitree Maoleekoonpairoj; Arkom Cheirsilpa; Vichien Srimuninnimit; Prasert Lertsanguansinchai; Vicharn Lorvidhaya; Ekaphop Sirachainan; Pramook Phromratanapongse; Saipin Tangkaratt; Pitayapoon Pattaranutaporn; Mahidol University; Chiang Mai University; Pramongkutklao Hospital; National Cancer Institute Thailand; Chulalongkorn University
1-Feb-2013A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancerSuthinee Ithimakin; Adune Ratanawichitrasin; Vutisiri Veerasarn; Charuwan Akewanlop; Nopadol Soparattanapaisarn; Supakorn Rojananin; Pornchai O-charoenrat; Poramaporn Prasarttong-osoth; Vichien Srimuninnimit; Mahidol University
10-Feb-2001Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancerVorachai Ratanatharathorn; Vicharn Lorvidhaya; Savitree Maoleekoonpairoj; Pramook Phromratanapongse; Suwannee Sirilerttrakul; Puangthong Kraipiboon; Arkom Cheirsilpa; Saipin Tangkaratt; Vichien Srimuninnimit; Pitayapoon Pattaranutaporn; Mahidol University; Chiang Mai University; Pramongkutklao Hospital; National Cancer Institute Thailand
1-Jan-2013Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2Kathleen I. Pritchard; Howard A. Burris; Yoshinori Ito; Hope S. Rugo; Shaker Dakhil; Gabriel N. Hortobagyi; Mario Campone; Tibor Csöszi; José Baselga; Puttisak Puttawibul; Martine Piccart; Daniel Heng; Shinzaburo Noguchi; Vichien Srimuninnimit; Hugues Bourgeois; Antonio Gonzalez Martin; Karen Osborne; Ashok Panneerselvam; Tetiana Taran; Tarek Sahmoud; Michael Gnant; University of Toronto; Sarah Cannon Research Institute; Cancer Institute Hospital of Japan Foundation for Cancer Research; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Center of Kansas; University of Texas MD Anderson Cancer Center; Centre de Recherche en Cancérologie; Hetenyi Geza County Hospital; Memorial Sloan-Kettering Cancer Center; Prince of Songkla University; Institut Jules Bordet; University of Calgary; Osaka University; Mahidol University; Centre Jean Bernard; MD Anderson Cancer Center, Madrid; Novartis International AG; Novartis Pharmaceuticals Corporation; Medizinische Universitat Wien
1-Aug-2001Uracil with ftorafur and low dose oral folinic acid in advanced colorectal cancerSurachat Chakrapee-Sirisuk; Pairoj Sinlarat; Darin Lohsiriwat; Narong Lert-Akayamanee; Thanyadej Nimmanwudipong; Vichien Srimuninnimit; Vithya Vathanophas; Pairoach Arch-Yaemsuan; Wiroon Boonnuch; Mahidol University